Home › Pinealoma
Pinealoma clinical trials recruiting in the U.S.
7 studies for Pinealoma are recruiting participants at sites across the United States.
Recently updated studies
International PPB/DICER1 Registry
RecruitingObservational studyHealthy volunteers welcome
0 Minutes – 100 Years · All sexes · Updated Oct 26, 2026 · NCT03382158Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)
RecruitingPhase 1
Ages 1 to 30 · All sexes · Updated Oct 13, 2026 · NCT06193759GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults
RecruitingPhase 1
Ages 1 to 30 · All sexes · Updated Oct 9, 2026 · NCT07087002A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors
RecruitingPhase 1
Ages 5 to 18 · All sexes · Updated Sep 15, 2026 · NCT06357377B7-H3.CD28Z.CART in CNS Neoplasms
RecruitingPhase 1
Ages 2 to 21 · All sexes · Updated Sep 3, 2026 · NCT07390539A Phase 0/1 Study of cDNA for TP53, Checkpoint Inhibition and Radiation in Children With Recurrent, Progressive or Refractory CNS Malignancies.
RecruitingEarly phase 1
Ages 3 to 21 · All sexes · Updated Apr 29, 2026 · NCT07017816Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors
RecruitingPhase 1
Ages 1 to 26 · All sexes · Updated Apr 13, 2026 · NCT04185038From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.